Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |